SAN DIEGO, Feb. 18, 2011 /PRNewswire/ — Zimmer Holdings, Inc.
(NYSE:
ZMH; SIX: ZMH), a leader in musculoskeletal care, today
announced it has received FDA clearance for the TM-S Trabecular
Metal™ Cervical Interbody Fusion Device.  The TM-S
system is the industry’s first cervical interbody device
incorporating porous metal technology, and the first Zimmer
Trabecular Metal device for cervical interbody fusion (IBF)
in the United States.

The TM-S system is constructed from Zimmer’s proprietary
Trabecular Metal Technology, a unique porous metal
biomaterial with structural and mechanical properties similar to
cancellous bone.  Trabecular Metal Material provides an
osteoconductive scaffold which supports bony in-growth and
vascularization into the implant.  Utilized in cervical
interbody fusion, the properties of Trabecular Metal
Material provide an excellent environment for bone growth.
 

“With the introduction of the TM-S system, Zimmer is bringing
the potential benefits of porous metal technology to cervical
interbody fusion,” said Steve Healy, President, Zimmer Spine.
 “The osteoconductive properties of Trabecular Metal
Technology support initial fixation and can potentially aid in
cervical fusion.”

The TM-S Cervical Fusion Device is intended for use with
supplemental fixation systems and with autogenous bone graft.
 The device is designed to treat the cervical spine of
patients with degenerative disc disease with or without radicular
symptoms at one level from C2-T1.  

The TM-S Cervical Fusion Device will be on display at the 2011
American Academy of Orthopaedic Surgeons (AAOS) annual meeting.
 Zimmer Spine will also be hosting hands-on training for the
device at the Company’s exhibit at AAOS 2011.  For more
information about Trabecular Metal Technology, vis

‘/>”/>

SOURCE